Revance Therapeutics Market Cap

IDX:IMPC has a market cap or net worth of 44.77 trillion as of August 13, 2025. Its market cap has increased by 137.07% in one year.

Market Cap

44.77T

Enterprise Value

46.19T

Revenue

3.98T

Ranking

n/a

PE Ratio

79.63

Stock Price

$825.00

Market Cap Chart

Since December 17, 2014, IDX:IMPC's market cap has increased from 2.76T to 44.77T, an increase of 1,525.04%. That is a compound annual growth rate of 29.89%.

Market Cap History

Date	Market Cap	% Change
Aug 12, 2025	44.77T	122.97%
Dec 30, 2024	20.08T	-4.64%
Dec 29, 2023	21.06T	21.25%
Dec 30, 2022	17.37T	40.90%
Dec 30, 2021	12.33T	92.45%
Dec 30, 2020	6,404.39B	26.19%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PT Astra International Tbk	199.18T
PT Transcoal Pacific Tbk	30.38T
PT Jasa Marga (Persero) Tbk	25.55T
PT Surya Semesta Internusa Tbk	11.56T
PT Ancara Logistics Indonesia Tbk	9,020.71B
PT Wijaya Karya (Persero) Tbk	8,133.88B
PT Citra Marga Nusaphala Persada Tbk	7,881.66B
PT Temas Tbk.	7,222.34B

Market Cap Rankings